Archana Kulkarni-Munje, Medical Writer at Fortrea, shared on LinkedIn:
“I’m delighted to share that our article has been published in the British Journal of Cancer (Nature Portfolio).
It was a privilege to collaborate with an exceptional multidisciplinary team of experts from academia, clinical practice, industry, and research organizations. Working alongside such accomplished co-authors made this a truly enriching experience.
I am grateful to all co-authors for their expertise, collaboration, and commitment. It’s rewarding to contribute to research that can help inform future policy and support advancements in cancer clinical research.”
Title: Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework
Authors: Paulina Czajka-Francuz, Chris Twelves, James Spicer, Archana Munje, Laura Vidal, Ruth Plummer, Dinesh Mistry, Maksym Novikov, Jim Bush, Gopalakrishnan Srinivasan, Soma Das, Sharan Sandhu, Vikram Bohra, Chinmayee Joshi, Ken Morrison, Suvarna Chavan, Fiona Thistlethwaite, Andrew Walding, Glen Clack, Michael George, Debashis Sarker, Raghib Ali, Sarah P. Blagden, Thomas R. Jeffry Evans, Kamal S. Saini
You can also read:
Nicholas Birda։ New Article Calls For a New Strategy in Paediatric Cancer Drug Development
